U S Stem Cell Inc 's ability to collect accounts receivable sequentially worsen to 16.32, pointing to a challenging and on top of that deteriorating business climate for the Medical Laboratories industry. U S Stem Cell Inc 's Accounts Receivable average collection period in the Dec 31 2022 quarter, has increased to 22 days, from 18 days, in the Sep 30 2022 quarter.

If we take a look into Healthcare sector 88 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 919, from overall ranking in the third quarter 2022 at 1721.

What is Receivable Turnover Ratio?
What is U S Stem Cell Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

USRM Receivables Turnover Ratio	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter
Y / Y Receivable Change	257.13 %	-90.87 %	-76.25 %	-95.77 %	-97.76 %
Y / Y Revenue Change	-15.34 %	-75.15 %	-30.82 %	-72.37 %	-79.54 %
Receivable Turnover Ratio (TTM)	16.32	20.17	10.56	7.48	4.54
USRM's Total Ranking	# 919	# 1721	# 436	# 918	# 919
Accounts Receivable average collection period days	22	18	35	49	80
Seq. Receivable Change	35.71 %	-60.43 %	78.51 %	272.55 %	-96.53 %
Seq. Revenue Change	40.2 %	-41.89 %	5.18 %	-1.2 %	-58.85 %

Receivable Turnover Company Ranking
Within:	No.
Medical Laboratories Industry	# 2
Healthcare Sector	# 89
Overall Market	# 919

Receivable Turnover Ratio Statistics
High	Average	Low
181.9	56.06	-69.67
(Jun 30 2019)		(Dec 31 2020)

USRM Company Profile • Back to USRM Efficiency Comparisons • Compare USRM Receivables Turnover Ratio to its Competitors

Financial Statements
U S Stem Cell Inc 's Accounts Receivable	$ 0 Millions	Visit USRM's Balance sheet
U S Stem Cell Inc 's Sales TTM	$ 0 Millions	Visit USRM's Income Statement
Sources of USRM's Revenues		Visit USRM's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
USRM's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
USRM's Growth Rates	USRM's Roa	USRM's Inventory Turnover Ratio	USRM's Dividend Comparisons
USRM's Profitability Ratios	USRM's Roi	USRM's Asset Turnover Ratio	USRM's Dividend Growth
USRM's Valuation Ratios	USRM's Roe	USRM's Financial Strength Ratios	USRM's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2022	Receivable at quarter ending Dec 31 2022
Aclaris Therapeutics Inc	50.62	$ 29.752 Millions	$ 0.588 Millions
Lifemd Inc	48.51	$ 117.433 Millions	$ 2.421 Millions
Arcus Biosciences Inc	47.84	$ 112.000 Millions	$ 2.341 Millions
Sonida Senior Living Inc	47.33	$ 238.433 Millions	$ 5.037 Millions
Nanobiotix S a	47.29	$ 5.349 Millions	$ 0.113 Millions
Histogen Inc	45.96	$ 3.769 Millions	$ 0.082 Millions
Ideaya Biosciences Inc	43.86	$ 50.931 Millions	$ 1.161 Millions
Valneva Se	43.54	$ 404.659 Millions	$ 9.295 Millions
Spero Therapeutics Inc	41.34	$ 53.509 Millions	$ 1.294 Millions
Nature s Sunshine Products inc	40.28	$ 421.910 Millions	$ 10.474 Millions
Icecure Medical Ltd	39.55	$ 3.085 Millions	$ 0.078 Millions
Logicmark Inc	39.35	$ 11.916 Millions	$ 0.303 Millions
Provention Bio Inc	37.95	$ 12.895 Millions	$ 0.340 Millions
Greenbrook Tms Inc	37.61	$ 69.104 Millions	$ 1.837 Millions
Cytokinetics Incorporated	36.14	$ 94.588 Millions	$ 2.617 Millions
Tvardi Therapeutics Inc	36.08	$ 41.867 Millions	$ 1.160 Millions
Science 37 Holdings Inc	34.07	$ 70.147 Millions	$ 2.059 Millions
Zymeworks Inc	33.98	$ 412.482 Millions	$ 12.138 Millions
Collplant Biotechnologies Ltd	33.22	$ 0.299 Millions	$ 0.009 Millions
Skinvisible Inc	32.73	$ 0.279 Millions	$ 0.009 Millions
Stoke Therapeutics Inc	31.05	$ 12.405 Millions	$ 0.399 Millions
Verrica Pharmaceuticals Inc	30.96	$ 9.032 Millions	$ 0.292 Millions
Calliditas Therapeutics Ab	30.58	$ 86.309 Millions	$ 2.823 Millions
Iterum Therapeutics Plc	30.53	$ 5.458 Millions	$ 0.179 Millions
National Vision Holdings Inc	29.74	$ 2,005.404 Millions	$ 67.434 Millions
Vireo Growth Inc.	27.05	$ 74.626 Millions	$ 2.759 Millions
Altamira Therapeutics Ltd	26.25	$ 0.306 Millions	$ 0.012 Millions
Nurix Therapeutics Inc	25.75	$ 38.627 Millions	$ 1.500 Millions
Inmed Pharmaceuticals Inc	25.29	$ 1.615 Millions	$ 0.064 Millions
Gsk Plc	24.56	$ 29,324.000 Millions	$ 1,194.000 Millions

Date modified: 2026-06-22T14:32:27+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.